Company Filing History:
Years Active: 2010-2012
Title: Natalya Vasilevich: Innovator in Stearoyl-CoA Desaturase Inhibitors
Introduction
Natalya Vasilevich is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that act as stearoyl-CoA desaturase inhibitors. With a total of four patents to her name, her work is aimed at addressing various human diseases related to lipid metabolism.
Latest Patents
Among her latest patents, Vasilevich has developed 3,4-dihydroquinoxalin-2(1H)-ones for use as stearoyl-CoA desaturase inhibitors. This invention discloses compounds that are useful in treating and preventing diseases mediated by stearoyl-CoA desaturase enzymes. These diseases include those related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, and metabolic syndrome. Additionally, she has patented pyrido[2,3-B]pyrazinones, which also serve as inhibitors of stearoyl-CoA desaturase, further contributing to the treatment of similar health issues.
Career Highlights
Vasilevich has worked with notable companies such as Gilead Palo Alto, Inc. and Gilead Sciences, Inc. Her experience in these organizations has allowed her to collaborate on innovative projects that push the boundaries of medical science.
Collaborations
Some of her coworkers include Dmitry Koltun and Jeff A Zablocki. Their collaborative efforts have likely contributed to the success of her inventions and patents.
Conclusion
Natalya Vasilevich is a key figure in the development of stearoyl-CoA desaturase inhibitors, with a focus on addressing critical health issues. Her innovative work continues to pave the way for advancements in medical treatments.